Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Vancomycin in Complicated Cellulitis
NCT01626560Phase 4Completed
- Sponsor
- Hospital Universitário Evangélico Mackenzie
- Start
- Jul 2012
- Primary completion
- Mar 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of daptomycin in cellulitis, erysipelas, sponsored by Hospital Universitário Evangélico Mackenzie. Started Jul 2012; status: completed.
02
Drugs
daptomycin
03
Conditions
cellulitiserysipelas
Beyond the preview
Go deeper on NCT01626560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01626560.